Prognostic factors in maxillary sinus and nasal cavity carcinoma
Tài liệu tham khảo
Schantz, 2001, Tumors of the nasal cavity and paranasal sinuses, nasopharynx, oral cavity, and oropharynx, 797
Greene FL, Page DL, Fleming ID, Fritz AG, Balch Ch, Haller DG, et al. Nasal cavity and paranasal sinuses. In: Greene FL, Page DL, Fleming ID, Fritz AG, Balch Ch, Haller DG, Morrow M, editors. American Joint Committee on Cancer: AJCC cancer staging handbook. 6th ed. New York, NY: Springer-Verlag New York, Inc.; 2002. p. 73–80.
Dulguerov, 2001, Nasal and paranasal sinus carcinoma: are we making progress?, Cancer, 92, 3012, 10.1002/1097-0142(20011215)92:12<3012::AID-CNCR10131>3.0.CO;2-E
Myers, 2002, Paranasal sinus malignancies: an 18-year single institution experience, Laryngoscope, 112, 1964, 10.1097/00005537-200211000-00010
Spiro, 1997, Maxillectomy and its classification, Head Neck, 19, 309, 10.1002/(SICI)1097-0347(199707)19:4<309::AID-HED9>3.0.CO;2-4
Cordeiro, 2000, A classification system and algorithm for maxillectomy and reconstruction of midfacial defects, Plast Reconstr Surg, 105, 2331, 10.1097/00006534-200006000-00004
Close, 1996, Medial maxillectomy, 24
Kaplan, 1958, Nonparametric estimation from incomplete observations, J Am Stat Soc, 53, 457, 10.1080/01621459.1958.10501452
Feinstein, 1996, Proportional hazards analysis (Cox regression), 10.2307/j.ctt2250wks.18
Yoshimura, 2002, Trimodal combination therapy for maxillary sinus carcinoma, Int J Radiat Oncol Biol Phys, 53, 656, 10.1016/S0360-3016(02)02771-2
Le, 1999, Treatment of maxillary sinus carcinoma, Cancer, 86, 1700, 10.1002/(SICI)1097-0142(19991101)86:9<1700::AID-CNCR11>3.0.CO;2-4
Cantu, 1999, A new classification for malignant tumors involving the anterior skull base, Arch Otolaryngol Head Neck Surg, 125, 1252, 10.1001/archotol.125.11.1252
Nishino, 2003, Results of orbital preservation for advanced malignant maxillary sinus tumors, Laryngoscope, 113, 1064, 10.1097/00005537-200306000-00028
Imola, 2002, Orbital preservation in surgical management of sinonasal malignancy, Laryngoscope, 112, 1357, 10.1097/00005537-200208000-00007
Papadimitrakopoulou, 2003, Intraarterial cisplatin with intravenous paclitaxel and ifosfamide as an organ-preservation approach in patients with paranasal sinus carcinoma, Cancer, 98, 2214, 10.1002/cncr.11771
Carrillo, 2004, Anterolateral and lateral skull-base approaches for treatment of neoplastic diseases, Am J Otolaryngol, 25, 58, 10.1016/S0196-0709(03)00094-2
Bigelow, 1999, Treatment of malignant neoplasms of the cranial base with the combined frontotemporal-anterolateral approach: five year follow-up, Otolaryngol Head Neck Surg, 120, 17, 10.1016/S0194-5998(99)70364-5
Myers, 2002, Paranasal sinus malignancies: an 18 year single institution experience, Laryngoscope, 112, 1964, 10.1097/00005537-200211000-00010
Jeremic, 2000, Elective ipsilateral neck irradiation of patients with locally advanced maxillary sinus carcinoma, Cancer, 88, 2246, 10.1002/(SICI)1097-0142(20000515)88:10<2246::AID-CNCR7>3.0.CO;2-S
Paulino, 1997, Is prophylactic neck irradiation indicated in patients with squamous cell carcinoma of the maxillary sinus?, Int J Radiat Oncol Biol Phys, 39, 283, 10.1016/S0360-3016(97)00293-9
Hanna, 2003, Cancer of the nasal cavity, paranasal sinuses and orbit, 155
Suárez, 2004, Prognostic factors in sinonasal tumors involving the anterior skull base, Head Neck, 26, 136, 10.1002/hed.10358
Carrillo, 2005, Osteoplastic maxillotomy for the treatment of neoplasms of the nasopharynx and infratemporal fossa, Ann Otol Rhinol Laryngol, 104, 58, 10.1177/000348940511400111